- Tempus to buy cancer test-maker Personalis for $1.5BTempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.BioPharma Dive · 8d ago↗ source
- UnitedHealth Group lays out progress in AI pushAfter announcing a hefty investment in AI earlier this year, UnitedHealth laid out how it's using the technology across its business in a quarter that landed better than expected. The health insure…Endpoints · 8d ago↗ source
- House lawmakers back trade probe of China biotech, sequencingAt least 10 House lawmakers are backing a US trade panel’s probe of China’s biotech sector and related pricing practices, encouraging future executive action. In a letter sent to Secretary of the U…Endpoints · 8d ago